Cargando…

Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy

An elderly Japanese woman developed acute decompensated heart failure caused by persistent atrial fibrillation (AF) and left ventricular systolic dysfunction. Approximately 6 days after starting intravenous administration of amiodarone (600 mg/day) for maintaining sinus rhythm after cardioversion of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Koji, Yamashita, Mina, Sakaue, Tomoki, Enomoto, Daijiro, Uemura, Shigeki, Okura, Takafumi, Ikeda, Shuntaro, Takemoto, Masafumi, Utsunomiya, Yutaka, Hyodo, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588365/ https://www.ncbi.nlm.nih.gov/pubmed/33755267 http://dx.doi.org/10.1111/anec.12842

Ejemplares similares

Premature atrial contractions with multiple patterns of aberrant conduction followed by torsade de pointes in a patient with polymyalgia rheumatica: A case report
por: Takahashi, Koji, et al.
Publicado: (2021)

Variant Angina with Spontaneously Documented Ischemia- and Tachycardia-induced “Lambda” Waves
por: Takahashi, Koji, et al.
Publicado: (2021)

Aslanger’s sign in 12-lead electrocardiogram
por: Takahashi, Koji, et al.
Publicado: (2023)

Light chain cardiac amyloidosis in a nonagenarian
por: Takahashi, Koji, et al.
Publicado: (2022)

Vasospasm in the First Septal Perforator Branch and Late High-Grade Atrioventricular Block Following Successful Primary Percutaneous Coronary Intervention for the Proximal Left Anterior Descending Coronary Artery: A Case Report
por: Takahashi, Koji, et al.
Publicado: (2023)

Extracardiac Accumulation of Technetium-99m-Pyrophosphate in Transthyretin Cardiac Amyloidosis
por: Takahashi, Koji, et al.
Publicado: (2021)

Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia Syndrome as a Clinical Profile Leading to the Diagnosis of Transthyretin Amyloidosis: A Report of Two Cases
por: Takahashi, Koji, et al.
Publicado: (2022)

Iatrogenic intramuscular hematoma of the oblique muscles as a complication of technetium-99m-labeled pyrophosphate imaging-based computed tomography-guided core-needle biopsy in a patient with wild-type transthyretin cardiac amyloidosis
por: Takahashi, Koji, et al.
Publicado: (2023)

Amiodarone: Torsade de pointes: case report
Publicado: (2022)

Identification of the Vessels Causing Myocardial Ischemia by a Synthesized 18-Lead Electrocardiogram Obtained After the Master Two-Step Exercise Test in a Patient With Effort Angina
por: Takahashi, Koji, et al.
Publicado: (2023)

Phenytoin in treatment of amiodarone-induced Torsades de pointes
por: Mukhopadhyay, Saibal, et al.
Publicado: (2012)

Incidence of drug-induced torsades de pointes with intravenous amiodarone
por: Shenthar, Jayaprakash, et al.
Publicado: (2017)

Torsade de Pointes and Persistent QTc Prolongation after Intravenous Amiodarone
por: Kotsia, Anna P., et al.
Publicado: (2012)

Short‐term use of oral amiodarone causing torsades de pointes
por: Yau, Stephen, et al.
Publicado: (2018)

Torsades de Pointes and Prolonged Self-Terminating Ventricular Fibrillation Induced by Amiodarone
por: Tziatzios, Georgios D, et al.
Publicado: (2020)

Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
por: Nordkin, Irina, et al.
Publicado: (2020)

Landiolol suppression of electrical storm of torsades de pointes in patients with congenital long-QT syndrome type 2 and myocardial ischemia
por: Kitajima, Ryota, et al.
Publicado: (2017)

Torsade de pointes induced by intravenous amiodarone therapy accompanied by marked augmentation of the transmural dispersion of repolarization in a patient with tachycardia‐induced‐cardiomyopathy
por: Yonai, Ryo, et al.
Publicado: (2020)

Suppression of cardiac memory–related severe form of torsades de pointes by landiolol in a patient with congenital long QT syndrome type 2
por: Otsuki, Sou, et al.
Publicado: (2020)

Spasm Provocation Tests under Medication May Help Decide on Medical or Mechanical Therapy in Patients with Aborted Sudden Cardiac Death due to Coronary Spasm
por: Sueda, Shozo, et al.
Publicado: (2020)

Sequential Spasm Provocation Tests under Medications Are Indispensable in Patients with Aborted Sudden Cardiac Death due to Coronary Spasm
por: Sueda, Shozo, et al.
Publicado: (2020)

His Bundle Pacing in Amiodarone-Induced Complete Heart Block, QT Prolongation, and Torsade de Pointes
por: Tan, Vern Hsen, et al.
Publicado: (2020)

Amiodarone-induced life-threatening torsade de pointes in an end-stage lung cancer patient receiving gefitinib
por: Han, Dan, et al.
Publicado: (2019)

TORSADES DE POINTES IN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION TREATED BY SHORT-TERM PARENTERAL AMIODARONE THERAPY
por: Lakušić, Nenad, et al.
Publicado: (2019)

Takotsubo cardiomyopathy in amiodarone-induced hyperthyroidism
por: Capel, Ismael, et al.
Publicado: (2017)

Comparison of landiolol and amiodarone for the treatment of new-onset atrial fibrillation after cardiac surgery (FAAC) trial: study protocol for a randomized controlled trial
por: Caspersen, Edouard, et al.
Publicado: (2023)

Sepsis-Induced Takotsubo Cardiomyopathy Leading to Torsades de Pointes
por: Patel, Nirav, et al.
Publicado: (2016)

Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies
por: Ashida, Atsuko, et al.
Publicado: (2021)

Mid-Term Prognosis After Landiolol Treatment in Atrial Fibrillation/Atrial Flutter Patients With Chronic Heart Failure　― A Prospective Observational Survey (AF-CHF Landiolol Survey) ―
por: Yamashita, Takeshi, et al.
Publicado: (2020)

Safety and effective use of landiolol in the ICU
por: Hifumi, Toru, et al.
Publicado: (2014)

Long QT Syndrome and Torsade de Pointes Associated with Takotsubo Cardiomyopathy
por: Ahn, Ji Hun, et al.
Publicado: (2011)

Amiodarone Induced Thyrotoxicosis in the Setting of End Stage Cardiomyopathy
por: Anderson, Karolina, et al.
Publicado: (2021)

Study of hemodynamics in patients treated with landiolol in the ICU
por: Imabayashi, T, et al.
Publicado: (2009)

Landiolol for managing atrial fibrillation in intensive care
por: Rehberg, Sebastian, et al.
Publicado: (2018)

Landiolol for managing post-operative atrial fibrillation
por: Balik, Martin, et al.
Publicado: (2018)

Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
por: Kinugawa, Koichiro, et al.
Publicado: (2014)

Efficacy and Safety of Landiolol in Patients With Ventricular Tachyarrhythmias With or Without Renal Impairment　― Subanalysis of the J-Land II Study ―
por: Shiga, Tsuyoshi, et al.
Publicado: (2020)

Efficacy of Intravenous Administration of Landiolol in Patients With Acute Heart Failure and Supraventricular Tachyarrhythmia
por: Kiuchi, Shunsuke, et al.
Publicado: (2017)

Erratum to: Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
por: Kinugawa, Koichiro, et al.
Publicado: (2014)

Clinical Outcomes and Provoked Epicardial Spasm Phenotypes via Intracoronary Acetylcholine Testing in 680 Patients with Angina and Nonobstructive Coronary Arteries
por: Sueda, Shozo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8c1s70bufr4i442c0e4eje6ac6